Latest Articles & Resources FEATURED FDA Scrutiny Is Exposing a CDMO Quality Oversight Crisis Read More » FDA Scrutiny Is Exposing a CDMO Quality Oversight Crisis Read More » LATEST NEWS + INTERVIEWS AmbioPharm Invests $118.96 Million in South Carolina Peptide Manufacturing Expansion Mabion Extends Novavax Manufacturing Agreement Through 2029 SK pharmteco Partners With OTXL to Advance Rare Disease Therapies Matica Bio Launches Korea IIT Platform for Cell and Gene Therapy Development MilliporeSigma and KBI Biopharma Partner on Integrated ADC Development Services Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility Alcami Invests in Tennessee Facility Following Tjoapack Acquisition Resilience Relocates Corporate Headquarters from California to Ohio Simtra BioPharma CCO: “Manufacturing in the Region for the Region Is Here to Stay” WuXi Biologics Secures Fourth EMA GMP Certification for Suzhou Facility Sandoz Opens USD 99 Million Biosimilar Development Centre in Slovenia Bispecific Antibody CDMO: Market Size & Outsourcing Guide 2026 Siegfried Inaugurates New API Manufacturing Facility in Germany Proteomics Gains Ground Across the Pharmaceutical Value Chain Matica Bio Adds Cirsium Biosciences to Open Access Platform for AAV Manufacturing CG MedTech Signs CDMO Agreement With Kolon Pharma for hECM Tissue Products Skylark Bio Partners With Forge Biologics for AAV Gene Therapy Manufacturing TriLink Opens GMP Enzyme Manufacturing Facility in Florida for RNA Therapeutics Supply Neuland Laboratories to Invest $20 Million in Process Development and Kilo Lab Expansion Catalent Launches Qai AI Tool to Enhance Quality Management Across Global Network Mabion Signs LoI With Oddifact to Advance MabionCD20 in Rare Diseases PODCAST INTERVIEWS Simtra BioPharma CCO: “Manufacturing in the Region for the Region Is Here to Stay” Closing the Valley of Death: The Infrastructure Gap Holding Back Early-Stage Biologics Programs How Sanofi Navigates Regulatory CMC Across Global Markets: Insights from Manda Pasarkar
